Promising Data for Allo-Transplant After CAR T-Cell Failure in LBCL

(MedPage Today) -- Allogeneic stem-cell transplantation (allo-SCT) after CAR T-cell failure led to durable remissions in patients with relapsed/refractory large B-cell lymphoma (LBCL), according to data from a multicenter series. The results showed...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news